Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine.
Vaccination against yellow fever is effective, but available live virus vaccines are not recommended for use in immunocompromised or elderly patients. We report the successful and uneventful immunization of a 62-year-old man with a history of allogeneic bone marrow transplant and discuss evidence for this recommendation.
Yax
Justin A
JA
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Farnon
Eileen C
EC
Cary Engleberg
N
N
D016026:Bone Marrow Transplantation; D000075202:Contraindications; D004484:Ecuador; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous; D015004:Yellow Fever / Q000517:prevention & control; D022341:Yellow Fever Vaccine / Q000008:administration & dosage*
D022341:Yellow Fever Vaccine